Vault-13

Knoll Capital Management, LLC

MIAMI, FL · CIK 1325083 · 13F filing filed 2023-02-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$44.3m reported value -74.1% vs Q3 2022
21positions
83.0%in top 10
6 new 2 added 3 reduced 18 sold out vs Q3 2022

Holdings, Q4 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 1,948,090 $13.6m30.60% 30.60% AddedShares held: Q3 2022 1.9m, Q4 2022 1.9m +70.8k +70,785 3.8%
2 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 450,422 $6.3m14.11% 14.11% ReducedShares held: Q3 2022 900.8k, Q4 2022 450.4k -450.4k -450,422 -50.0%
3 ALTIMMUNE INC COM NEW ALT ALT 173,864 $2.9m6.45% 6.45% UnchangedShares held: Q3 2022 173.9k, Q4 2022 173.9k
4 VANECK ETF TRUST GOLD MINERS ETF GDX GDX 91,850 $2.6m5.94% 5.94% NewShares held: Q3 2022 0, Q4 2022 91.8k
5 GLOBAL X FDS GLOBAL X SILVER SIL SIL 89,700 $2.5m5.70% 5.70% NewShares held: Q3 2022 0, Q4 2022 89.7k
6 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 95,391 $2.5m5.63% 5.63% NewShares held: Q3 2022 0, Q4 2022 95.4k
7 VANECK ETF TRUST JUNIOR GOLD MINE GDXJ GDXJ 53,150 $1.9m4.28% 4.28% NewShares held: Q3 2022 0, Q4 2022 53.1k
8 APPLIED THERAPEUTICS INC COM APLT APLT 2,450,000 $1.9m4.20% 4.20% AddedShares held: Q3 2022 1.1m, Q4 2022 2.5m +1.4m +1,367,877 126.4%
9 BOOZ ALLEN HAMILTON HLDG COR CL A BAH BAH 13,000 $1.4m3.07% 3.07% UnchangedShares held: Q3 2022 13.0k, Q4 2022 13.0k
10 CVS HEALTH CORP COM CVS CVS 14,500 $1.4m3.05% 3.05% UnchangedShares held: Q3 2022 14.5k, Q4 2022 14.5k
11 Orgenesis, Inc. COM COM 634,738 $1.2m2.79% 2.79% ReducedShares held: Q3 2022 1.3m, Q4 2022 634.7k -681.6k -681,626 -51.8%
12 THERMO FISHER SCIENTIFIC INC COM TMO TMO 2,100 $1.2m2.61% 2.61% UnchangedShares held: Q3 2022 2.1k, Q4 2022 2.1k
13 AVADEL PHARMACEUTICALS PLC SPONSORED ADR SPONSORED ADR 150,000 $1.1m2.42% 2.42% NewShares held: Q3 2022 0, Q4 2022 150.0k
14 ALTRIA GROUP INC COM MO MO 22,700 $1.0m2.34% 2.34% UnchangedShares held: Q3 2022 22.7k, Q4 2022 22.7k
15 VISA INC COM CL A V V 4,850 $1.0m2.27% 2.27% UnchangedShares held: Q3 2022 4.8k, Q4 2022 4.8k
16 BLACKSTONE GROUP L P COM UNIT LTD BX BX 10,000 $741.9k1.67% 1.67% UnchangedShares held: Q3 2022 10.0k, Q4 2022 10.0k
17 OSISKO GOLD ROYALTIES LTD COM COM 235,000 $607.7k1.37% 1.37% UnchangedShares held: Q3 2022 235.0k, Q4 2022 235.0k
18 SEABRIDGE GOLD INC COM COM 41,000 $515.8k1.16% 1.16% UnchangedShares held: Q3 2022 41.0k, Q4 2022 41.0k
19 Anavex Life Sciences Corp COM NEW COM NEW 10,681 $98.9k0.22% 0.22% ReducedShares held: Q3 2022 210.8k, Q4 2022 10.7k -200.1k -200,108 -94.9%
20 HOOKIPA PHARMA INC COM COM 50,000 $40.5k0.09% 0.09% NewShares held: Q3 2022 0, Q4 2022 50.0k
21 ENTERA BIO LTD SHS ENTX ENTX 2,484,275 $2.6k0.01% 0.01% UnchangedShares held: Q3 2022 2.5m, Q4 2022 2.5m

Sold out since Q3 2022

SecurityTickerShares held beforeValue then
CORBUS PHARMACEUTICALS HLDGS CRBP CRBP 5,045,870 $833.0k5.0m shares
CORNING INC GLW GLW 26,600 $773.0k26.6k shares
AGNICO EAGLE MINES LTD AEM AEM 15,393 $650.0k15.4k shares
MAG SILVER CORP MAG MAG 48,000 $599.0k48.0k shares
EIGER BIOPHARMACEUTICALS INC CLDN CLDN 585,966 $586.0k586.0k shares
FRANCO NEV CORP FNV FNV 4,900 $585.0k4.9k shares
MAVERIX METALS INC 165,000 $553.0k165.0k shares
SILVERCREST METALS INC SIL SIL 100,000 $553.0k100.0k shares
WHEATON PRECIOUS METALS CORP WPM WPM 16,500 $534.0k16.5k shares
PAN AMERN SILVER CORP PAAS PAAS 29,500 $468.0k29.5k shares
EQUINOX GOLD CORP EQX EQX 99,000 $361.0k99.0k shares
MIRATI THERAPEUTICS INC MRTX MRTX 5,000 $349.0k5.0k shares
ABEONA THERAPEUTICS INC 88,629 $269.0k88.6k shares
BIOXCEL THERAPEUTICS INC 20,000 $236.0k20.0k shares
CONTEXT THERAPEUTICS INC CNTX CNTX 139,520 $155.0k139.5k shares
ANNOVIS BIO INC ANVS ANVS 14,210 $147.0k14.2k shares
ORAMED PHARMACEUTICALS INC ORMP ORMP 20,000 $130.0k20.0k shares
SOLIGENIX INC 34,766 $15.0k34.8k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 ELTX 5.3%≈ $4.7m +0.1 pts 13G 2026-07-08